I firmly believe that whatever price that last CR was done at...

I firmly believe that whatever price that last CR was done at would have made no difference to the current SP. Yes, we would have had a little less dilution but we would still have been hammered like everyone else in the Li sector. Look no further than PMT. They raised about $100M through CFTF at over $12/share the month before WR1, and in addition have released a couple of batches of pretty decent assay results as well. But none of that 'good' news saved them from the lash and now even a large resource upgrade isn't capable of lifting them.